Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
Add more filters










Publication year range
1.
J Agric Food Chem ; 68(41): 11350-11357, 2020 Oct 14.
Article in English | MEDLINE | ID: mdl-32956590

ABSTRACT

Plant diseases are seriously endangering agricultural production. The emergence of drug resistance has brought great challenges to the prevention and control of plant diseases. There is an urgent need for the emergence of new drug candidates. In this work, we achieved the efficient synthesis of pulmonarins A and B in 64% and 59% overall yield, respectively. Pulmonarins A and B were found to have good antiviral activities against tobacco mosaic virus (TMV) for the first time. A series of pulmonarin derivatives were designed, synthesized, and evaluated for their antiviral and fungicidal activities systematically. Most compounds displayed higher anti-TMV activities than commercial ribavirin. Compounds 6a, 6c, and 6n with better inactivation effects than ningnanmycin emerged as new antiviral candidates. We selected 6c for further antiviral mechanism research, which revealed that it could inhibit virus assembly by interacting with TMV coat protein (CP). The molecular docking results further confirmed that these compounds could interact with CP through hydrogen bonding. These compounds also displayed broad spectrum fungicidal activities. Especially compound 6u with prominent antifungal activity emerged as a new fungicidal candidate for further research. The current work provides a reference for understanding the application of pulmonarin alkaloids in plant protection.


Subject(s)
Antiviral Agents/pharmacology , Biological Products/pharmacology , Bromobenzenes/pharmacology , Fungicides, Industrial/pharmacology , Antiviral Agents/chemical synthesis , Antiviral Agents/chemistry , Biological Products/chemical synthesis , Biological Products/chemistry , Bromobenzenes/chemical synthesis , Bromobenzenes/chemistry , Fungi/drug effects , Fungi/growth & development , Fungicides, Industrial/chemical synthesis , Fungicides, Industrial/chemistry , Molecular Docking Simulation , Plant Diseases/microbiology , Plant Diseases/virology , Structure-Activity Relationship , Tobacco Mosaic Virus/drug effects , Tobacco Mosaic Virus/growth & development
2.
Bioorg Chem ; 85: 128-139, 2019 04.
Article in English | MEDLINE | ID: mdl-30605886

ABSTRACT

Starting from vanillin, known four benzyl bromides with Br were synthesized. The first synthesis of natural product 3,4-dibromo-5-((methylsulfonyl)methyl)benzene-1,2-diol (2) and 3,4,6-tribromo-5-((methylsulfonyl)methyl)benzene-1,2-diol (3) and derivatives were carried out by demethylation, acetylatilation, oxidation and hydrolysis reactions of the benzyl bromides. Also, these compounds were tested against some important enzymes like acetylcholinesterase and butyrylcholinesterase enzymes, carbonic anhydrase I, and II isoenzymes. The novel bromophenols showed Ki values of in range of 53.75 ±â€¯12.54-234.68 ±â€¯46.76 nM against hCA I, 42.84 ±â€¯9.36 and 200.54 ±â€¯57.25 nM against hCA II, 0.84 ±â€¯0.12-14.63 ±â€¯3.06 nM against AChE and 0.93 ±â€¯0.20-18.53 ±â€¯5.06 nM against BChE. Induced fit docking process performed on the compounds inhibiting hCA I, hCA II, AChE, and BChE receptors. Hydroxyl group should exist at the aromatic ring of the compounds for inhibition of the enzymes. The moieties reported in this study will be useful for design of more potent and selective inhibitors against the enzymes.


Subject(s)
Biological Products/chemical synthesis , Bromobenzenes/chemical synthesis , Carbonic Anhydrase Inhibitors/chemical synthesis , Cholinergic Antagonists/chemical synthesis , Phenols/chemical synthesis , Acetylcholinesterase/chemistry , Acetylcholinesterase/metabolism , Biological Products/metabolism , Biological Products/pharmacokinetics , Bromobenzenes/metabolism , Bromobenzenes/pharmacokinetics , Butyrylcholinesterase/chemistry , Butyrylcholinesterase/metabolism , Carbonic Anhydrase I/chemistry , Carbonic Anhydrase I/metabolism , Carbonic Anhydrase II/chemistry , Carbonic Anhydrase II/metabolism , Carbonic Anhydrase Inhibitors/metabolism , Carbonic Anhydrase Inhibitors/pharmacokinetics , Cholinergic Antagonists/metabolism , Cholinergic Antagonists/pharmacokinetics , Cholinesterase Inhibitors/chemical synthesis , Cholinesterase Inhibitors/metabolism , Cholinesterase Inhibitors/pharmacokinetics , Humans , Molecular Docking Simulation , Phenols/metabolism , Phenols/pharmacokinetics , Protein Binding
3.
J Org Chem ; 82(7): 3432-3440, 2017 04 07.
Article in English | MEDLINE | ID: mdl-28282140

ABSTRACT

In order to survive in a mammalian host, Mycobacterium tuberculosis (Mtb) produces aryl-capped siderophores known as the mycobactins for iron acquisition. Salicylic acid is a key building block of the mycobactin core and is synthesized by the bifunctional enzyme MbtI, which converts chorismate into isochorismate via a SN2″ reaction followed by further transformation into salicylate through a [3,3]-sigmatropic rearrangement. MbtI belongs to a family of chorismate-utilizing enzymes (CUEs) that have conserved topology and active site residues. The transition-state inhibitor 1 described by Bartlett, Kozlowski, and co-workers is the most potent reported inhibitor to date of CUEs. Herein, we disclose a concise asymmetric synthesis and the accompanying biochemical characterization of 1 along with three closely related analogues beginning from bromobenzene cis-1S,2S-dihydrodiol produced through microbial oxidation that features a series of regio- and stereoselective transformations for introduction of the C-4 hydroxy and C-6 amino substituents. The flexible synthesis enables late-stage introduction of the carboxy group and other bioisosteres at the C-1 position as well as installation of the enol-pyruvate side chain at the C-5 position.


Subject(s)
Bromobenzenes/pharmacology , Cyclohexenes/pharmacology , Enzyme Inhibitors/pharmacology , Lyases/antagonists & inhibitors , Mycobacterium tuberculosis/enzymology , Bromobenzenes/chemical synthesis , Bromobenzenes/chemistry , Cyclohexenes/chemical synthesis , Cyclohexenes/chemistry , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Lyases/metabolism , Molecular Structure , Structure-Activity Relationship
4.
Molecules ; 21(6)2016 Jun 08.
Article in English | MEDLINE | ID: mdl-27338322

ABSTRACT

A series of C2-symmetric chiral benzimidazolium salts, the precursor of N-heterocyclic carbene ligands, were designed and synthesized from 1,2-dibromobenzene. In situ prepared corresponding carbenes were tested in the asymmetric palladium-catalyzed intramolecular α-arylation of amides, affording chiral diarylmethanols with high yields and moderate enantioselectivities.


Subject(s)
Amides/chemistry , Anesthetics, Local/chemistry , Bromobenzenes/chemistry , Indoles/chemistry , Amides/chemical synthesis , Anesthetics, Local/chemical synthesis , Bromobenzenes/chemical synthesis , Catalysis , Indoles/chemical synthesis , Methane/analogs & derivatives , Methane/chemistry , Palladium/chemistry , Salts/chemistry , Stereoisomerism
5.
Bioorg Med Chem Lett ; 26(2): 460-465, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26684853

ABSTRACT

A series of novel hexahydropyrrolo[2,3-b]indole-1H-imidazolium salts were synthesized and evaluated in vitro against a panel of human tumor cell lines. The results suggest that the 5,6-dimethyl-benzimidazole ring, and substitution of the imidazolyl-3-position with a 2-bromobenzyl or 2-naphthylmethyl group, were important for the cytotoxic activity. Notably, Compound 43, bearing a 2-bromobenzyl substituent at position-3 of 5,6-dimethyl-benzimidazole, was found to possess the most potent derivative against five human tumor cell lines with IC50 values below 2.68µM and more selective towards SMMC-7721, A549 and SW480 cell lines. Compounds 25 and 39 were more selective to HL-60 and MCF-7 cell lines with IC50 values of 0.47 and 1.46µM.


Subject(s)
Antineoplastic Agents/pharmacology , Imidazoles/pharmacology , Indoles/pharmacology , Pyrroles/pharmacology , Antineoplastic Agents/chemical synthesis , Benzimidazoles/chemical synthesis , Benzimidazoles/pharmacology , Bromobenzenes/chemical synthesis , Bromobenzenes/pharmacology , Cell Line, Tumor , Drug Screening Assays, Antitumor , Humans , Imidazoles/chemical synthesis , Indoles/chemical synthesis , Naphthalenes/chemical synthesis , Naphthalenes/pharmacology , Pyrroles/chemical synthesis , Structure-Activity Relationship
6.
J Nat Prod ; 77(9): 2105-13, 2014 Sep 26.
Article in English | MEDLINE | ID: mdl-25181423

ABSTRACT

The current study describes the antifouling properties of four members belonging to the recently discovered synoxazolidinone and pulmonarin families, isolated from the sub-Arctic sessile ascidian Synoicum pulmonaria collected off the Norwegian coast. Four simplified synthetic analogues were also prepared and included in the study. Several of the studied compounds displayed MIC values in the micro-nanomolar range against 16 relevant marine species involved in both the micro- and macrofouling process. Settlement studies on Balanus improvisus cyprids indicated a deterrent effect and a low toxicity for selected compounds. The two synoxazolidinones displayed broad activity and are shown to be among the most active natural antifouling bromotyrosine derivatives described. Synoxazolidinone C displayed selected antifouling properties comparable to the commercial antifouling product Sea-Nine-211. The pulmonarins prevented the growth of several bacterial strains at nanomolar concentrations but displayed a lower activity toward microalgae and no effect on barnacles. The linear and cyclic synthetic peptidic mimics also displayed potent antifouling activities mainly directed against bacterial adhesion and growth.


Subject(s)
Biofouling , Bromobenzenes/isolation & purification , Guanidine/analogs & derivatives , Oxazolidinones/isolation & purification , Urochordata/chemistry , Animals , Bromobenzenes/chemical synthesis , Bromobenzenes/chemistry , Bromobenzenes/pharmacology , Guanidine/chemical synthesis , Guanidine/chemistry , Guanidine/isolation & purification , Guanidine/pharmacology , Guanidines , Larva/drug effects , Marine Biology , Molecular Structure , Oxazolidinones/chemical synthesis , Oxazolidinones/chemistry , Oxazolidinones/pharmacology , Thoracica/physiology
7.
Angew Chem Int Ed Engl ; 53(22): 5552-5, 2014 May 26.
Article in English | MEDLINE | ID: mdl-24757079

ABSTRACT

Lithiation/borylation methodology has been developed for the synthesis of acyclic quaternary-tertiary motifs with full control of relative and absolute stereochemistry, thus leading to all four possible isomers of a stereodiad. A novel intramolecular Zweifel-type olefination enabled acyclic stereocontrol to be transformed into cyclic stereocontrol. These key steps have been applied to the shortest enantioselective synthesis of (-)-filiformin to date (9 steps) with full stereocontrol.


Subject(s)
Bromobenzenes/chemical synthesis , Boronic Acids/chemistry , Bromobenzenes/chemistry , Carbamates/chemistry , Esters , Lithium/chemistry , Stereoisomerism
8.
Org Biomol Chem ; 10(10): 1969-75, 2012 Mar 14.
Article in English | MEDLINE | ID: mdl-22274301

ABSTRACT

Diverse 11H-indeno[1,2-c]quinolines are produced via a palladium-catalyzed three-component reaction of 2-alkynylbromobenzene, 2-alkynylaniline, and electrophile. This conversion tolerates a wide variety of functionality and substitution patterns on the 11H-indeno[1,2-c]quinoline ring.


Subject(s)
Aniline Compounds/chemistry , Bromobenzenes/chemistry , Indenes/chemical synthesis , Palladium/chemistry , Quinolines/chemical synthesis , Aniline Compounds/chemical synthesis , Bromobenzenes/chemical synthesis , Catalysis , Indenes/chemistry , Quinolines/chemistry
9.
J Enzyme Inhib Med Chem ; 27(1): 43-50, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21635211

ABSTRACT

(2-Bromo-3,4-dimethoxyphenyl) (3,4-dimethoxyphenyl)methanone (10) and its derivatives with Br, one dibromide and isomeric three tribromides, were synthesized. Demethylation of these compounds afforded a series of new bromophenols. Inhibition of human cytosolic carbonic anhydrase II (hCA II) isozyme by these new bromophenols and naturally occurring 3,4,6-tribromo-5-(2,5-dibromo-3,4-dihydroxybenzyl)benzene-1,2-diol (3), and 5,5'-methylenebis(3,4,6-tribromo-benzene-1,2-diol) (4) was investigated. The synthesized compounds showed carbonic anhydrase inhibitory capacities with IC(50) values in the range of 0.7-372 µM against hCA II. Some bromophenols investigated here showed effective hCA II inhibitory activity and might be used as leads for generating novel carbonic anhydrase inhibitors which are valuable drug candidates for the treatment of glaucoma, epilepsy, gastric and duodenal ulcers, neurological disorders, or osteoporosis.


Subject(s)
Benzophenones/pharmacology , Biological Products/pharmacology , Bromobenzenes/pharmacology , Carbonic Anhydrase II/antagonists & inhibitors , Carbonic Anhydrase Inhibitors/pharmacology , Catechols/pharmacology , Benzophenones/chemical synthesis , Benzophenones/chemistry , Biological Products/chemical synthesis , Biological Products/chemistry , Bromobenzenes/chemical synthesis , Bromobenzenes/chemistry , Carbonic Anhydrase II/metabolism , Carbonic Anhydrase Inhibitors/chemical synthesis , Carbonic Anhydrase Inhibitors/chemistry , Catechols/chemical synthesis , Catechols/chemistry , Cytosol/enzymology , Dose-Response Relationship, Drug , Humans , Isoenzymes/antagonists & inhibitors , Isoenzymes/metabolism , Molecular Structure , Stereoisomerism , Structure-Activity Relationship
10.
J Nucl Med ; 51(9): 1472-9, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20720048

ABSTRACT

UNLABELLED: Meta-iodobenzylguanidine (MIBG) labeled with (123)I or (131)I has been widely used for the diagnosis and radiotherapy of norepinephrine transporter (NET)-expressing tumors. However, (123)I/(131)I-MIBG has limitations for detecting small lesions because of its lower spatial resolution than PET tracers. In this study, meta-bromobenzylguanidine (MBBG) labeled with (76)Br (half-life, 16.1 h), an attractive positron emitter, was prepared and evaluated as a potential PET tracer for imaging NET-expressing tumors. METHODS: (76)Br-MBBG was prepared by a halogen-exchange reaction between the (76)Br and iodine of nonradioactive MIBG. The stability of MBBG was evaluated in vitro and in vivo by high-performance liquid chromatography analysis. Cellular uptake studies with or without NET inhibitors were performed in NET-positive PC-12 cell lines. Biodistribution studies were performed in PC-12 tumor-bearing nude mice by administration of a mixed solution of MBBG, MIBG, and (18)F-FDG. The tumor was imaged using (76)Br-MBBG and (18)F-FDG with a small-animal PET scanner. RESULTS: MBBG was stable in vitro, but some time-dependent dehalogenation was observed after administration in mice. MBBG showed high uptake in PC-12 tumor cells that was significantly decreased by the addition of NET inhibitors. In biodistribution studies, MBBG showed high tumor accumulation (32.0 +/- 18.6 percentage injected dose per gram at 3 h after administration), and the tumor-to-blood ratio reached as high as 54.4 +/- 31.9 at 3 h after administration. The tumor uptake of MBBG correlated well with that of MIBG (r = 0.997) but not with that of (18)F-FDG. (76)Br-MBBG PET showed a clear image of the transplanted tumor, with high sensitivity, which was different from the lesion shown by (18)F-FDG PET. CONCLUSION: (76)Br-MBBG showed high tumor accumulation, which correlated well with that of MIBG, and provided a clear PET image. These results indicated that (76)Br-MBBG would be a potential PET tracer for imaging NET-expressing neuroendocrine tumors and could provide useful information for determining the indications for (131)I-MIBG therapy.


Subject(s)
Bromobenzenes , Gene Expression Regulation, Neoplastic , Guanidines , Neoplasms/diagnostic imaging , Neoplasms/genetics , Positron-Emission Tomography/methods , Receptors, Adrenergic/metabolism , Animals , Biological Transport , Bromobenzenes/chemical synthesis , Bromobenzenes/metabolism , Bromobenzenes/pharmacokinetics , Fluorodeoxyglucose F18 , Guanidines/chemical synthesis , Guanidines/metabolism , Guanidines/pharmacokinetics , Mice , Neoplasms/metabolism , Neoplasms/pathology , PC12 Cells , Rats
11.
Oncol Rep ; 23(5): 1435-41, 2010 May.
Article in English | MEDLINE | ID: mdl-20372861

ABSTRACT

The aim of the present study was to investigate the apoptosis of human hepatocellular carcinoma cell line HepG 2 induced by a new curcumin analogue, GL63. HepG 2 cells were treated with increasing doses of GL63 and curcumin for 48 h. The proliferation of cells was detected with MTT. The apoptosis were examined by flow cytometry. The caspase-3 activity was detected by western blotting. ER calcium stores were assessed by the fluorescent calcium indicator fura-2/AM. The protein expression of ER stress pathway, GRP78, XBP-1, ATF-4 and CHOP were examined with western blotting. Growth inhibitory effect was observed for treatment with GL63 in a dose-dependent manner and with more potential than curcumin. GL63 at 20 microM induced significant apoptosis in HepG 2 cells. Furthermore, GL63 induced the ER stress response, up-regulation of CHOP, XBP-1, ATF-4 and GRP78 expression in a dose-dependent, while curcumin had no effect on ER stress. These results suggest that GL63 has more potent anti-tumor activity than curcumin, which is associated with activation of ER stress and induction of apoptosis in HepG 2 cells.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Bromobenzenes/pharmacology , Carcinoma, Hepatocellular/pathology , Curcumin/pharmacology , Liver Neoplasms/pathology , Pentanones/pharmacology , Activating Transcription Factor 4/metabolism , Animals , Antineoplastic Agents, Phytogenic/chemical synthesis , Blotting, Western , Bromobenzenes/chemical synthesis , Calcium/metabolism , Carcinoma, Hepatocellular/metabolism , Caspase 3/metabolism , Cell Survival/drug effects , Curcumin/analogs & derivatives , Curcumin/chemical synthesis , DNA-Binding Proteins/metabolism , Dose-Response Relationship, Drug , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/metabolism , Endoplasmic Reticulum Chaperone BiP , Flow Cytometry , Heat-Shock Proteins/metabolism , Hep G2 Cells , Humans , Liver Neoplasms/metabolism , Pentanones/chemical synthesis , Rats , Regulatory Factor X Transcription Factors , Stress, Physiological/drug effects , Time Factors , Transcription Factor CHOP/metabolism , Transcription Factors/metabolism , X-Box Binding Protein 1
12.
Org Biomol Chem ; 7(19): 3991-9, 2009 Oct 07.
Article in English | MEDLINE | ID: mdl-19763302

ABSTRACT

Treatment of primary amines with tetramethylphenylguanidine (PhTMG) and a cyanophosphonate at -10 degrees Celsius under an atmosphere of carbon dioxide provides cyanoformamides in very high to excellent yields. The reaction proceeds efficiently within a short time. By-products were not detected in most runs and epimerization was not found when optically pure alpha-aminoesters were used as substrates. As an example, the reaction was applied to the synthesis of the marine natural product ceratinamine.


Subject(s)
Amines/chemistry , Bromobenzenes/chemical synthesis , Carbon Dioxide/chemistry , Formamides/chemical synthesis , Nitriles/chemistry , Nitriles/chemical synthesis , Amino Alcohols/chemistry , Atmospheric Pressure , Bromobenzenes/chemistry , Formamides/chemistry , Organophosphonates/chemistry , Oxazolidinones/chemistry , Temperature
13.
J Org Chem ; 74(12): 4646-9, 2009 Jun 19.
Article in English | MEDLINE | ID: mdl-19518154

ABSTRACT

Chiral pyrimidines with a fluorine atom in the benzylic position are easily accessible in high enantiomeric excesses from optically active propargylic intermediates by two complementary routes. Both the use of optically active propargylic fluorides and the fluorination of the chiral pyrimidine in the final stage give excellent results in terms of enantiocontrol. On the other hand, original pyrimidines with a difluoromethyl side chain are also obtained in a few steps from new propargylic ketones bearing a CHF(2) substituent on the triple bond.


Subject(s)
Hydrocarbons, Fluorinated/chemical synthesis , Pyrimidines/chemical synthesis , Alkynes/chemistry , Bromobenzenes/chemical synthesis , Bromobenzenes/chemistry , Hydrocarbons, Fluorinated/chemistry , Ketones/chemistry
14.
J Org Chem ; 74(3): 995-1006, 2009 Feb 06.
Article in English | MEDLINE | ID: mdl-19128042

ABSTRACT

Two synthetic approaches to the microtubule-stabilizing ceratamine alkaloids are described. The first approach involved attempts to graft an aminoimidazole moiety onto an azepine ring to form partially hydrogenated versions of the unprecedented aromatic imidazo[4,5-d]azepine core of the ceratamines. This route ultimately failed because it was not possible to aromatize the partially hydrogenated ceratamine intermediates. A second approach started with tribromoimidazole that was sequentially metalated and functionalized to efficiently generate a key imidazole intermediate containing vinyl bromide and amide functionalities. An intramolecular Buchwald vinyl amidation reaction converted this key intermediate into a bicyclic imidazo[4,5-d]azepine that was at the same oxidation state as the aromatic core of the ceratamines. The 2-amino functionality present on the imidazole ring of the ceratamines was installed using a Buchwald/Hartwig amination reaction on a 2-chloroimidazole precursor. Deprotection and aromatization resulted in the first synthesis of desbromoceratamine A (55) and desmethyldesbromoceratamine A (60). An unanticipated addition of atmospheric oxygen was encountered during deprotection of the imidazole ring in the last step of the synthesis leading to C-11 oxygenated ceratamine analogues as byproducts. Evaluation of the synthetic ceratamines in a TG3 cell-based assay for mitotic arrest revealed that the C-14 and C-16 bromine substituents in ceratamine A (1) play a major role in the antimitotic potency of the natural product. The synthetic route to ceratamine analogues has provided sufficient quantities of desbromoceratamine A (55) for testing in mouse models of cancer.


Subject(s)
Alkaloids/chemical synthesis , Azepines/chemical synthesis , Imidazoles/chemical synthesis , Animals , Bromobenzenes/chemical synthesis , Porifera/chemistry
15.
Molecules ; 12(11): 2478-83, 2007 Nov 12.
Article in English | MEDLINE | ID: mdl-18065952

ABSTRACT

Certain substituted bromobenzenes have been synthesized in acceptable yields using a novel Sandmeyer type reaction. The reactions are relatively quick and possibly proceed via a radical mechanism.


Subject(s)
Bromine/chemistry , Bromobenzenes/chemical synthesis , Aniline Compounds/chemistry , Bromobenzenes/chemistry , Models, Chemical , Molecular Structure
16.
Spectrochim Acta A Mol Biomol Spectrosc ; 67(3-4): 808-14, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17046319

ABSTRACT

Schiff bases derived from different meta-substituted salicylaldehyde and 5-methylaminopyridine have been synthesized and characterized by elemental analysis, FT-IR, NMR and UV-vis techniques. NMR assignments were made using (1)H, (13)C NMR and aided by 2D HETCOR and HMBC heteronuclear correlation techniques. The UV-vis spectra of the compounds were found useful in understanding the existence of tautomeric equilibria [phenol-imine (O-H...N) and keto-amine (O...H-N) forms] in polar and non-polar solvents. In order to rationalize the stabilization of tautomer in solid state, X-ray structure of 2-[(1E)-2-aza-2-(5-methyl(2-pyridyl)ethenyl)]-4-bromobenzen-1-ol (6) was determined. According to our crystallographic result, it has enol-imine tautomeric form.


Subject(s)
Aldehydes/chemical synthesis , Aza Compounds/chemical synthesis , Bromobenzenes/chemical synthesis , Pyridines/chemical synthesis , Schiff Bases/chemical synthesis , Aldehydes/chemistry , Aza Compounds/chemistry , Bromobenzenes/chemistry , Crystallization , Magnetic Resonance Imaging , Molecular Structure , Pyridines/chemistry , Schiff Bases/chemistry , Spectrophotometry, Infrared , Spectrophotometry, Ultraviolet , Spectroscopy, Fourier Transform Infrared , Stereoisomerism , X-Ray Diffraction
17.
J Med Chem ; 49(6): 2063-76, 2006 Mar 23.
Article in English | MEDLINE | ID: mdl-16539395

ABSTRACT

Cytoplasmic dynein plays important roles in membrane transport, mitosis, and other cellular processes. A few small-molecule inhibitors of cytoplasmic dynein have been identified. We report here the first synthesis of purealin, a natural product isolated from the sea sponge Psammaplysilla purea, which is known to inhibit axonemal dynein. Also described are the first syntheses, by modular amide coupling reactions, of the natural product purealidin A (a component of purealin) and a small library of analogues. The library was examined for inhibition of cytoplasmic dynein heavy chain and cell growth. The compounds showed effective antiproliferative activity against a mouse leukemia cell line but selective activities against human carcinoma cell lines. Purealin and some of the analogues inhibited the microtubule-stimulated ATPase activity of recombinant cytoplasmic dynein heavy chain motor domain. The inhibitory effect of purealin was concentration dependent and uncompetitive, supporting the hypothesis that it does not compete with the binding of ATP.


Subject(s)
Antineoplastic Agents/chemical synthesis , Bromobenzenes/chemical synthesis , Dyneins/antagonists & inhibitors , Adenosine Triphosphatases/chemistry , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Bromobenzenes/chemistry , Bromobenzenes/pharmacology , Cell Line, Tumor , Cell Proliferation/drug effects , Cytoplasm/enzymology , Drug Screening Assays, Antitumor , Humans , Kinetics , Mice , Porifera , Protein Structure, Tertiary , Rats , Recombinant Proteins/chemistry , Structure-Activity Relationship
18.
J Org Chem ; 71(5): 2188-91, 2006 Mar 03.
Article in English | MEDLINE | ID: mdl-16497017

ABSTRACT

A facile protocol for the synthesis of 1,2-dibromoarenes is described. A standard ortho-lithiation/bromination procedure, when applied to bromoarenes, resulted in poor yields of the corresponding 1,2-dibromoarenes (13-62% yield). However, transmetalation of the transient aryllithium intermediate to an arylzinc species with ZnCl2, followed by bromination, resulted in dramatically improved yields of the synthetically useful 1,2-dibromoarenes (68-95% yield).


Subject(s)
Bromine/chemistry , Bromobenzenes/chemical synthesis , Lithium/chemistry , Zinc/chemistry
19.
Curr Biol ; 15(11): 1070-6, 2005 Jun 07.
Article in English | MEDLINE | ID: mdl-15936280

ABSTRACT

The spindle checkpoint prevents chromosome loss by preventing chromosome segregation in cells with improperly attached chromosomes [1, 2 and 3]. The checkpoint senses defects in the attachment of chromosomes to the mitotic spindle [4] and the tension exerted on chromosomes by spindle forces in mitosis [5, 6 and 7]. Because many cancers have defects in chromosome segregation, this checkpoint may be required for survival of tumor cells and may be a target for chemotherapy. We performed a phenotype-based chemical-genetic screen in budding yeast and identified an inhibitor of the spindle checkpoint, called cincreasin. We used a genome-wide collection of yeast gene-deletion strains and traditional genetic and biochemical analysis to show that the target of cincreasin is Mps1, a protein kinase required for checkpoint function [8]. Despite the requirement for Mps1 for sensing both the lack of microtubule attachment and tension at kinetochores, we find concentrations of cincreasin that selectively inhibit the tension-sensitive branch of the spindle checkpoint. At these concentrations, cincreasin causes lethal chromosome missegregation in mutants that display chromosomal instability. Our results demonstrate that Mps1 can be exploited as a target and that inhibiting the tension-sensitive branch of the spindle checkpoint may be a way of selectively killing cancer cells that display chromosomal instability.


Subject(s)
Bromobenzenes/pharmacology , Chromosome Segregation/drug effects , Mitosis/physiology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/antagonists & inhibitors , Saccharomyces cerevisiae Proteins/antagonists & inhibitors , Saccharomyces cerevisiae/physiology , Spindle Apparatus/drug effects , Bromobenzenes/chemical synthesis , Bromobenzenes/metabolism , Chromosome Segregation/physiology , DNA Primers , Dimethyl Sulfoxide , Dose-Response Relationship, Drug , Kinetochores/metabolism , Microarray Analysis , Microtubules/metabolism , Phenotype , Spindle Apparatus/metabolism , Spindle Apparatus/physiology
20.
Environ Int ; 31(1): 33-42, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15607777

ABSTRACT

For development of an indirect competitive enzyme-linked immunosorbent assay (ELISA) for the nitrile herbicide bromoxynil, the polyclonal antibodies raised against 2,6-dibromo-4-cyano-phenoxyacetic acid (hapten) conjugated to bovine serum albumin (BSA) by the N-hydroxysuccinimide-activated ester method. Antiserum with a sufficiently high titer to provide the determinations of targeted compounds was obtained only 77 days after the primary immunization. Antiserum A2 was applied to the residual analysis of some water samples, under optimized ELISA condition, the quantitative working range was from 10 to 500 ppb with a limit of detection of 5 ppb. Cross-reactivity to structurally similar agrochemicals and related chemicals was determined. The antiserum showed little cross-reactivity with 2,6-dibromophenol and bromoxynil octanoate ester which have a dibromophenol group as common structure, but showed no cross-reactivity with other herbicides. Each water sample (river water, tap water, purified water, and bottled water) had a matrix effect and was investigated by adding Tween20 in the assay buffer. These four kinds of water samples were fortified with bromoxynil at several concentration levels and were directly analyzed with only dilution with an equal volume of antiserum solution, the mean recovery was 102.3%, and the mean coefficient of variation was 5.96%. The proposed ELISA turned out to be a powerful tool for monitoring of residual bromoxynil in water samples at trace level.


Subject(s)
Bromobenzenes/immunology , Enzyme-Linked Immunosorbent Assay/methods , Herbicides/analysis , Immune Sera/immunology , Nitriles/analysis , Water/analysis , Animals , Bromobenzenes/chemical synthesis , Cross Reactions , Environmental Monitoring , Female , Haptens/immunology , Herbicides/immunology , Hydrogen-Ion Concentration , Immune Sera/biosynthesis , Immunization , Male , Nitriles/immunology , Polysorbates , Rabbits , Reproducibility of Results , Rivers/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...